More proof needed on costly diabetes drugs
(Reuters)
More proof needed on costly diabetes drugs
(Reuters)
Reuters - U.S. doctors are using a wider array of newer, more costly drugs to treat diabetes with little long-term proof that they work better than older, cheaper medications, U.S. researchers said on Monday.
More proof needed on costly diabetes drugs
(Reuters) details